Projects per year
Personal profile
Education/Academic qualification
Bachelor
Fingerprint
Dive into the research topics where Mourad Gumusboga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
TriDoRe: Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating More
Lynen, L., de Jong, B., Van Deun, A., Decroo, T., Gumusboga, M., Meehan, C., Lempens, P., Rigouts, L., Van Herrewege, Y., Buyze, J., Herssens, N. & Lynen, L.
1/10/18 → 30/09/24
Project: Research Project
-
BENIN - 2018 - FA4: Institutional strengthening of the Mycobacteria Reference Laboratory (LRM, Bénin) for quality services and better quality of health care for Mycobacteria and other clinical bacteria, at National and Regional Level.
de Jong, B., Jacobs, J., Hardy, L., Stassijns, J., Nduwamahoro, E., Eddyani, M., Gumusboga, M. & Janssens, N.
Directorate-General for Development Cooperation and Humanitarian Aid
1/01/18 → 31/12/18
Project: Development project
Research output
-
Successful Mycobacterium tuberculosis culture isolation from tongue swabs: Results from both experimentally infected and clinical swabs from pulmonary tuberculosis patients
Rigouts, L., Conde, M., Hassane-Harouna, S., Bah, K., Gumusboga, M., Ruhwald, M., Reenaers, R., Fissette, K., Gaichiri, M., De Vos, M. & De Jong, BC., 2024, In: Diagnostic Microbiology and Infectious Disease. 110, 2, 8 p., 116423.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
Van Deun, A., Bola, V., Lebeke, R., Kaswa, M., Hossain, M. A., Gumusboga, M., Torrea, G., De Jong, B. C., Rigouts, L. & Decroo, T., 2022, In: JAC-Antimicrobial Resistance. 4, 2, 9 p., dlac037.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile28 Downloads (Pure) -
Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
Decroo, T., Jai, K., Aung, M., Hossain, M. A., Gumusboga, M., Ortuno-Gutierrez, N., de Jong, B. C. & Van Deun, A., 2021, (E-pub ahead of print) In: European Respiratory Journal. 59, 3, 2102124.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile24 Downloads (Pure) -
Finding the right balance between efficacy and tolerability for TB treatment: the search continues
Maug, A. K. J., Hossain, M. A., Gumusboga, M., Decroo, T., Mulders, W., Braet, S., Buyze, J., Jiménez, D. A., Schurmans, C., Herssens, N., Demeulenaere, T., Lynen, L., de Jong, B. C. & Van Deun, A., 2021, In: International Journal of Tuberculosis and Lung Disease. 25, 1, p. 84-86 3 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile20 Downloads (Pure) -
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown
Van Deun, A., Decroo, T., Aung, K. J. M., Hossain, M. A., Gumusboga, M., De Rijk, W. B., Tahseen, S., de Jong, B. C. & Rigouts, L., 2021, In: European Respiratory Journal. 58, 3, 2100783.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile10 Downloads (Pure)